Episodes

  • At-Home Relief: Novel Drug Empowering Patients in Sickle Cell Crisis
    Jul 29 2024

    Over 90% of American sickle cell disease (SCD) patients are Black or African American, contributing to a history of underfunding and stigma. Patients in debilitating pain are misconstrued as drug seekers. What medicines they receive have side effects and fail to address the root cause.

    In this season’s finale, I interview John Paderi, Chief Scientific Officer at IHP Therapeutics. Inspired by Biodesign’s patient-centric approach, he is developing a novel, self-administered drug for SCD pain crisis.

    Join us to discover the SCD patient journey, shortcomings of existing therapies, and his learnings as CSO—risks, opportunities, strategy and all.

    We also explore how he integrates Biodesign with his academic training, surprising parallels between SCD and migraines, and his most rewarding moment at IHP so far!

    References:

    Overview on Sickle Cell Pain Management (Osunkwo et al.)

    Health Care Disparities in Sickle Cell Disease (Lee et al.)

    Impact of Opioid Epidemic on Sickle Cell Patients (Sinha et al.)

    Show More Show Less
    40 mins
  • Accessible Diagnostics with Paper, Printer and Pencil
    Jul 10 2024

    Low-cost, rapid, accurate, portable, heat-proof… These are just a few of the many boundary conditions Prof. Suman Chakraborty keeps in mind while designing for low-resource settings.

    Inspired by the simple arts and crafts we do in primary school, he builds paper-based frugal diagnostics. He explores the deep science in everyday items. Tune in to hear how he invented pencil-drawn electrodes and microfluidic channels you can print in any office!

    We also discuss the demand-supply gap in point-of-care devices, his recent push towards device-free testing, and his philosophy on keeping curiosity alive by pursuing simplicity of the mind.

    References:

    WHO India Health System Review (How Health Expenditures Drive Poverty)

    Publication from Chakraborty Lab on Paper-and-Pencil Microfluidics

    Show More Show Less
    45 mins
  • Portable, Painless and Privacy-Aware: Breast Imaging For All
    Jun 18 2024

    “We always love our technology,” Dr. Geetha says. “It’s easy to say - yeah, that false negative? It has to be false.” Today, I speak with the founder of Niramai, a safe, accessible AI-based cancer diagnostic that’s gone beyond buzzwords to create large-scale, global impact.

    Join us to hear how Dr. Geetha built the world’s largest database of thermal breast images, navigated doctors’ worries of being replaced by A.I., and adapted her product for diverse contexts, to be low-cost for rural screening and low-risk for quick FDA clearance.

    Along the way, she shares why cancer rates are increasing among young women, how entrepreneurship feels like racing down an empty highway, and the one thing in her daily routine she prizes more than food!

    References:

    Feature on Niramai and Breast Cancer Stats in India

    WHO Global Cancer Burden News Release

    Article Linking Breast Cancer, Childbirth, and Breastfeeding

    Youtube License Codes: YRVETGM2CE9Z5UVW, QX3HA65SLZLJAKWV, UR8BNRLMRASVSRDR

    Show More Show Less
    44 mins
  • Our Enemy’s Enemy: Can Phages Beat Antibacterial Resistance?
    May 16 2024

    In 2019, antimicrobial resistance (AMR) caused 1.27 million deaths around the world. Antibiotic misuse is making tried and trusted medicines ineffective against resistant superbugs.

    In this episode, I speak with Prof. Urmi Bajpai, co-Founder of the International Bacteriophage Research Consortium. We dissect how phages work, what we can and cannot engineer in them today, and why global coordination is essential going forward.

    Via the One Health lens, we explore the impact of climate change on AMR and how our war on bacteria is interconnected across sectors, from agriculture to medicine.

    Tune in to also catch Prof. Bajpai’s take on a fictional, futuristic phage-printer and her journey creating a Biomedical Science department from scratch!

    References:

    R&D Gaps in Phage Therapy

    Forbes Primer on Phage Therapy

    WHO Antimicrobial Resistance Fact Sheet

    Music License Codes: YHNLRERFHWIXNVJ0, XLV7SAFD5G0EXWND, 6ZMZK5UJG7ZAITZV

    Show More Show Less
    45 mins
  • Celsi’s Clinical Journey + The Invention Education Model
    Apr 30 2024

    Studies reveal >65% of babied admitted into Asian and African NICUs are hypothermic.

    In Part 3 of this series on neonatal health devices for low-resource settings, I speak with Sonia Sosa from the Rice360 Institute for Global Health Technologies. Through bite-sized student projects, they develop tools such as Celsi, a continuous monitor that alerts nurses of unchecked hypothermia.

    Tune in as Sonia shares clinical insights from Celsi’s creation and journey to FDA 510(k) clearance in 2023.

    We also explore what ‘low-resource setting’ truly means to her and how the Invention Education model is fostering creativity and entrepreneurship in Malawi and Tanzania!

    References:

    Neonatal Hypothermia Prevalence

    WHO Newborn Mortality Fact Sheet

    WHO Preterm Birth Fact Sheet

    Music License Codes: OSIYU3ZJ3NMOEBRB, BFIVSC8JRHFHEIYI, WGPKEPYQKZDP0V7R

    Show More Show Less
    47 mins
  • Integrating Tech Within Diverse Health Systems
    Apr 30 2024

    The Brilliance phototherapy device has touched the lives of over 1 million neonates with jaundice. Their trick? Probing deep into health systems to ask:

    • Who are the people and institutions providing care to underserved communities?
    • What does it take to earn their trust?
    • How do we embolden health workers to use their skills to the fullest?

    In Part 2 of this series spotlighting neonatal health technologies designed for low-resource settings, I welcome Krishnakumar Sankaranarayanan (KK), former MD of Equalize Health India. Join us as we uncover the technology and market strategy behind the successful adoption of Brilliance phototherapy device.

    Along the way, we explore the cost-quality tradeoff in engineering and why pharma giants haven’t been able to bridge the accessible tech gap just yet.

    References:

    Human-Centered Design Case Series Featuring “Brilliance”

    Equalize Health Impact Audit

    Music License Codes: 6RZ1QCMLRU5EUREW, UJMANWNDBCJ8SCFV, FBBXCULZLH4SQGLZ

    Show More Show Less
    40 mins
  • How To Escape The Device Graveyard: Low Cost CPAP Design
    Apr 30 2024

    “Device graveyards” clutter the basements and broom closets of crowded hospitals. As of 2010, a whooping 40% of medical devices in the developing world were out of service due to inadequate repair, training, or infrastructure.

    Join us for Part 1 of this series spotlighting neonatal health technologies created for low-resource settings. Today’s guest, Tanner Shioshita from Equalize Health, shares the design principles that helped him build a neonatal CPAP that’s affordable, user-friendly, and robust.

    Also discover his passion for engineering, and the unique culture that made his time at Equalize Health fun, creative, and fulfilling!

    References:

    How Much Medical Equipment is Broken in the Developing World?

    WHO Newborn Mortality Fact Sheet

    WHO Preterm Birth Fact Sheet

    Music License Codes: FXTEJTJTOPXZHPPG, 2YWHQJJMCDY1EQNM, WGSEZCGNDNYGLSIA, IUVMEDVMOQT3IG3F

    Show More Show Less
    39 mins